The activation of AKT (also called protein kinase B) is thought to be a critical step in the phosphoinositide 3-kinase pathway that regulates cell growth and differentiation. In this report, we investigated the role of AKT in the regulation of mouse early embryo development. Injection of mRNA coding for a constitutively active myristoylated AKT (myr-Akt1) into one-cell stage fertilized eggs induced cell division more effectively than injection of wild-type AKT (Akt1-WT) mRNA, whereas microinjection of mRNA of kinase-deficient AKT (Akt1-KD) delayed the first mitotic division. Meanwhile, microinjection of different kinds of mRNA of AKT affected the phosphorylation status of CDC2A-Tyr15 and the activation of M-phase promoting factor (MPF). To investigate the intermediate factor between AKT and MPF, we then injected one-cell stage eggs first with Akt1-WT mRNA or myr-Akt1 mRNA and then with mRNA encoding either wild-type CDC25B (Cdc25b-WT) or a AKT-nonphosphorylatable Ser351 to Ala CDC25B mutant (Cdc25b-S351A). Cdc25b-S351A strongly inhibited the effect of AKT. Therefore, AKT causes the activation of MPF and strongly promotes the development of one-cell stage mouse fertilized eggs by inducing AKT-dependent phosphorylation of CDC25B, a member of the CDC25 phosphatase family. Our finding that CDC25B acts as a potential target of AKT provides new insight into the effect of AKT in the regulation of early development of mouse embryos.
INTRODUCTION
Early embryonic division is characterized by a rapid succession of the interphase and mitotic state in many species. The progression through M phase is controlled by M-phase promoting factor (MPF) [1] , a highly conserved complex consisting of a kinase, CDC2A [2, 3] , and an activating subunit, CCNB1 [1, [4] [5] [6] . During the G2/M transition, MPF undergoes tight regulation by phosphorylation and dephosphorylation of CDC2A. In the G2 phase of vertebrate cells, CDC2A is kept inactivated by inhibitory phosphorylation on tyrosine 15 (Tyr15) and threonine 14 (Thr14), which are catalyzed by WEE 1/MYT 1 kinase [7] [8] [9] , and the CDC2A/ CCNB1 complex remains enzymatically inactive (pre-MPF) [10] . On entry into M phase, CDC25, a dual-specific phosphatase family, dephosphorylates CDC2A on both Tyr15 and Thr14, causing the activation of MPF [11, 12] . Thus, in principle, the G2/M transition can be induced by inactivation of WEE 1/MYT 1 kinase or activation of CDC25 phosphatase or both [13, 14] . However, it is unknown how the dominance between the activities of the WEE 1/MYT 1 kinase and CDC25 phosphatase is initially reversed to activate CDC2A/CCNB1 at entry into M phase.
AKT (also called protein kinase B) is known as a serine/ threonine protein kinase and a downstream factor of phosphoinositide 3-kinase (PI3K). It is well established that AKT plays an important role in cellular processes such as glucose metabolism, cell proliferation, apoptosis, transcription, and cell migration. The PI3K-AKT signaling pathway was reported to promote G1 progression through activation of the CDK4/ CCND1 complex [15] . By contrast, AKT is known to inactivate the CDK inhibitors CDKN1A and CDKN1B (previously known as p21 and p27). AKT phosphorylates CDKN1A on Thr145 and CDKN1B on Thr157 and Thr198, resulting in their cytoplasmic translocation and functional suppression [16] [17] [18] [19] [20] [21] . These results indicate that AKT promotes cell-cycle progression in G1 phase by activating positive regulators and inactivating negative ones. Otherwise, AKT is suggested to function as a G2/M initiator. AKT activation by overexpression of a constitutively active form or by the loss of PTEN (phosphatase and tensin homologue deleted in chromosome 10) could overcome the G2/M arrest that was induced by gamma irradiation [22] . In addition, PTEN-null embryonic stem (ES) cells were reported to transit faster from the G2/M to the G1 phase of the cell cycle than wild-type ES cells, and LY294002, an inhibitor of PI3K, elicited G2/M arrest in human embryonic kidney (HEK) 293 cells [22] . Although these results suggest that the PI3K-AKT signaling pathway strongly promotes G2/M transition in mammalian cell-cycle progression, the direct relationship between the PI3K-AKT signaling pathway and regulation of the G2/M transition is not fully understood. However, in primary oocytes from the starfish Asterina pectinifera, AKT was reported to inhibit MYT 1 through AKT-dependent phosphorylation and down-regulation at the G2/M transition [23] ; in HEK293T cells, AKT promotes G2/M cell-cycle progression by inducing phophorylationdependent YWHAQ (previously known as 14-3-3h) binding and cytoplasmic localization of WEE 1 kinase [24] . Moreover, as a result, AKT indirectly causes the activation of CDC2A and promotes the cell cycle progression at the G2/M transition. These findings suggest the possibility that the AKT functions as an M-phase initiator in mammals.
Despite the continuing discovery of new substrates of AKT and our increasing knowledge of their basic biochemistry and molecular biology, relatively little is known about the effect of AKT in the regulation of mammalian early embryo development. The mouse fertilized egg is the most simple and natural cell-cycle model in vertebrates that are close to human. There are few reports about the mechanism of the regulation of early development of mouse fertilized eggs, especially the events of entry into M-phase. Here we report that AKT causes the activation of MPF and strongly promotes the development of one-cell stage mouse fertilized eggs by inducing AKTdependent phosphorylation of CDC25B, a member of CDC25 phosphatase family. Our findings identify CDC25B as a potential target of AKT and provide new insight into the effect of AKT in the regulation of mouse early embryo development.
MATERIALS AND METHODS

Animals and Reagents
Kunming strain mice were obtained from the Department of Laboratory Animals, China Medical University (CMU). All experiments were performed at CMU in accordance with the NIH Guidelines for the Care and Use of Laboratory Animals. The protocol for animal handling and the treatment procedures were reviewed and approved by the CMU Animal Care and Use Committee. Reagents, unless otherwise specified, were from Sigma.
Collection and Culture of Mouse Embryos
One-cell stage mouse embryos were collected and cultured according to the method described by Hogan and Constantini [25] . Female mice at 4-6 wk old were abdominally injected with 10 IU of eCG and 48 h later with 10 IU hCG. A single female was placed with a single male for fertilization. One-cell embryos were collected with M2 medium the next day (20 h after hCG injection) from the oviduct of females possessing a vaginal plug. After injection with mRNA, embryos were cultured in a drop of M16 medium under paraffin oil at 378C in a humidified atmosphere of 5% CO 2 in air.
Construction of mRNA Expression Vectors
The constructs encoding the wild-type AKT (pCIS2-Akt1-WT), myristoylated AKT (pCIS2-myr-Akt1) and kinase-deficient AKT (pCIS2-Akt1-KD) were gifts from Michael J. Quon (National Institutes of Health) [26, 27] .
The coding sequences of wild-type AKT (Akt1-WT), kinase-deficient AKT (Akt1-KD), and myristoylated AKT (myr-Akt1) were amplified by PCR using the pCIS2-Akt1-WT, pCIS2-Akt1-KD, and pCIS2-myr-Akt1, respectively, as templates and introduced the enzyme-incision site of HindIII and BamHI into 5 0 and 3 0 end, respectively. The products were cloned into the mRNA expression vector pcDNA3.1/myc-His B (Invitrogen) and named pcDNA3.1-Akt1-WT, pcDNA3.1-Akt1-KD, and pcDNA3.1-myr-Akt1. The pBSK-Cdc25b-WT was subcloned into pcDNA3.1/myc-His B using KpnI and BamHI. The recombinant was called pcDNA3.1-Cdc25b-WT.
A Site-Directed Mutagenesis Kit (Stratagene) was used to mutate Ser351 to a nonphosphorylatable alanine of CDC25B, and this mutant was called pcDNA3.1-Cdc25b-S351A.
All the above recombinant plasmids were sequenced to verify the correct gene insertion and successful mutation and were used as templates for in vitro transcription.
In Vitro Transcription
All the constructs in pcDNA3.1/myc-His B were cut singly with AgeI and transcribed in vitro into 5 0 -capped mRNA for microinjection by using the mMESSAGE mMACHINE kit (Ambion). The in vitro-synthesized mRNA was dissolved in nuclease-free 5 mM Tris and 0.5 mM EDTA (TE; pH 7.4). We determined mRNA yield by measuring absorbance at 260 nm and by carrying out modified nondenaturing gels loaded with RNA.
Messenger RNA Microinjection and Observation of the Mouse Embryos
Various mRNA were injected into one-cell stage embryos at G2 phase using a micropipette and Eppendorf TransferMan manipulators mounted on an Olympus IX-70 inverted microscope with DIC optics. Eggs were placed in a drop of M2 medium under paraffin oil in the lid of a 3-cm Falcon culture dish. Typical injection volume was 5% of total cell volume or 10 pl per egg. Messenger RNA was diluted to various concentrations in TE buffer (pH 7.4) without nuclease contaminant. Eggs in control groups were either not microinjected or microinjected with TE buffer. The percentages of cell division and cell survival were counted under a dissecting microscope 30 h and 35 h after injection of hCG, and the results were analyzed statistically.
Assay of MPF Activity
MPF kinase activity was measured using histone H1 kinase assay [28] . Five eggs cultured in M16 medium were collected, washed in collection buffer (PBS containing 1 mg/ml polyvinyl alcohol, 5 mM EDTA, 10 mM Na 3 VO4, and 10 mM NaF), and then transferred to an Eppendorf tube containing 5 ll of the collection buffer. The Eppendorf tube was immediately stored at À708C until the kinase assay was performed.
The frozen eggs were thawed and subjected to freezing and thawing three times. A total of 25 ll of MPF buffer (54 , and 1 mg/L each of leupeptin, aprotonin, pepstatin, chymostatin, and trypsin-chymotrypsin inhibitor) was then added to the disrupted cells. The histone H1 kinase reaction was started by adding 25 ll of 20 lCi/ml [c- 32 P]ATP (Beijing FuRui Biotechnology) incubated at 308C for 10 min. Then 25-ll aliquots were spotted on Whatman p81 paper, and the reaction was stopped with 5% H 3 PO 4 solution. After thorough washing, the radioactivity on the filter paper was counted with a BECKMAN scintillation counter.
A parallel incubation was performed to confirm the phosphorylation of histone H1. Protein extract from 10 oocytes was incubated with 50 ll of MPF buffer containing 50 lCi/ml [c- 32 P]ATP at 378C for 30 min, and the reaction was stopped by adding an equal amount of 23 SDS buffer. The reaction was then resolved on a 12% SDS-PAGE gel, and the incorporation of 32 P into histone H1 was visualized by autoradiography.
Assay of PKB Activity
Ten eggs cultured in M16 medium were collected and lysed as described above and assayed for 30 min at room temperature in AKT reaction buffer containing 50 mM Hepes (pH 7.5), 10 mM MgCl 2 , 1 mM DTT, 1 lM PKI, 40 lCi/ml [c - 32 P]ATP, and 0.2 mg/ml histone H2B used as substrate. AKT activity was also determined by scintillation counting and autoradiography, as in the MPF activity assay.
Western Blotting
Protein extracts of mouse fertilized eggs were prepared by adding approximately 150 eggs in a minimal volume of collection medium to 20 ll of protein extraction buffer (100 mM NaCl, 20 mM Tris-HCL [pH 7.5], 0.5% Triton X-100, 0.5% NP-40) containing 1 mM phenylmethylsulfonyl fluoride and 1 lg/ml leupeptin and pepstatin. Laemmli sample buffer was added to the protein extracts, and the mixture was boiled for 5 min and resolved on a 12% SDS-PAGE gel. For immunoblotting, the fractionated proteins were transferred to a nitrocellulose membrane. The membrane was blocked with 3% BSA in Tris-buffered saline containing 0.05% Tween 20 and probed with primary antibodies in a sealed plastic bag at 48C overnight. The primary antibody against pTyr15 of CDC2A or CCNB1 (Santa Cruz Biotechnology) was used at 1:400 dilution, or the anti-MYC antibody (Invitrogen) used at 1:1000 dilution.
The membrane was then incubated with alkaline phosphatase-conjugated anti-mouse IgG secondary antibody at 1:3000 (Beijing Zhongshan Biotechnology). The proteins were detected by using O-dianidine and b-naphthyl acid phosphate as the substrates of alkaline phosphatase.
Statistical Analysis
One-way analysis of variance or Student t-test was used to evaluate the difference between groups, and differences at P , 0.05 were considered to be significant. SPSS 13.0 software was used to perform statistical analyses.
RESULTS
AKT mRNA Microinjection Interferes with Cell Division of One-Cell Stage Mouse Fertilized Eggs
To test whether AKT kinase activity and the membrane targeting are involved in the mitotic cell cycle of fertilized eggs, three AKT constructs encoding Akt1-WT, myr-Akt1, and Akt1-KD were used in our experiment. In the myr-Akt1 PROTEIN KINASE B/AKT IN MOUSE EGGS construct, the AKT coding region is fused to a myristoylation sequence from pp60 csk. This engineered protein is constitutively active in 3T3L1 cells by being targeted to the membrane [29] . The dominant inhibitory mutant of AKT that we used in this study is a kinase-deficient AKT that results from the substitution of alamine for lysine at position 179 in the canonical ATP-binding domain. This mutant is not only catalytically inactive but has been shown to inhibit the activity and actions of endogenous AKT. Indeed, these catalytically active and inactive mutants have been extensively characterized [30, 31, 32] and have been shown to have dominant effects in other contexts [26, 27, 33, 34] .
To examine whether AKT affects the mitotic cell cycle, onecell stage mouse fertilized eggs were cultured in M16 medium after microinjection of 0.03 ng mRNA of Akt1-WT, myr-Akt1, or Akt1-KD. Two control groups were non-microinjection or microinjection with TE buffer.
At 4 h after mRNA microinjection, 10 one-cell stage fertilized eggs cultured in M16 medium were collected for the assay of AKT activity. The results showed that the AKT activity in Akt1-WT mRNA-injected oocytes was higher than that of control groups, and AKT activity in the myr-Akt1 mRNA-injected group was 20-fold higher than that of control groups (P , 0.01), or about 8-to 10-fold higher than the Akt1-WT mRNA-injected group (P , 0.05). However, AKT activity in the Akt1-KD mRNA-injected group was lower than the control groups (P , 0.05) (Fig. 1A) . Western blot analysis showed that the AKT-MYC fusion protein accumulated at high levels in Akt1-WT, myr-Akt1, or Akt1-KD mRNA-injected onecell stage fertilized eggs (Fig. 1B) . These results indicate that the exogenous mRNA of all kinds of AKT could be translated efficiently, and the microinjection of Akt1 constructs could change the activity of AKT in the one-cell stage eggs.
The percentages of cell division and death in each group were calculated after counting under a dissecting microscope 30 h and 35 h after injection of hCG (Tables 1 and 2 ). In the control groups, embryos remained at the one-cell stage 26 h after hCG injection (G2 phase), but about 63% of embryos reached two-cell stage 4 h later (30 h after the injection of hCG), and there was no significant difference between the two control groups (P . 0.05). Embryos microinjected with mRNA of Akt1-WT were in one-cell stage 26 h after the hCG injection, FIG. 1 . The activity of AKT and the expression of AKT-myc after Akt1 constructs microinjection. A) 0.03 ng of mRNA coding Akt1-WT, myrAkt1, or Akt1-KD was injected into each egg; 50-60 eggs were injected. Eggs in control groups were either not microinjected or microinjected with TE buffer. After 4 h, 10 eggs were collected for the assay of AKT activity. AKT activity was analyzed as described in Materials and Methods. Each value was expressed as mean 6 SEM from four independent experiments. B) Western blot of AKT-MYC expression in different microinjected groups. Immunostaining was performed using anti-myc. The data shown are representative of at least three independent experiments. (Tables 1  and 2 ). These results demonstrated that microinjection of different kinds of mRNA of AKT can interfere with the time course of cell division of one-cell stage fertilized eggs, suggesting that AKT may have the biological function of promoting the early mitotic division in mouse early embryos.
Akt mRNA Microinjection Regulates MPF Activity and CDC2A-Tyr15 Phosphorylation
The promotion of the development of the one-cell stage by Akt1 mRNA microinjection into fertilized eggs suggests a role of AKT in regulating mouse embryonic cleavage.
Firstly, we investigated the time course for the activation of the endogenous AKT and MPF of one-cell stage fertilized eggs in control groups. Mice were primed with eCG for 48 h and then injected with hCG. Eggs were collected at the indicated timepoint after hCG injection for the assay of AKT activity and H1 kinase activity. As anticipated, the change in AKT activity preceded MPF activation (Fig. 2) . The activity of AKT reached a maximum at 26 h after hCG injection ( Fig. 2A) and preceded MPF activation by 2 h (Fig. 2B) . AKT activation was transient, and a substantial decrease was detected between 27 h and 30 h after hCG injection, although the MPF activity peak occurred during this period. These results suggest that endogenous AKT activation occurs prior to MPF activation during the first mitotic division of fertilized eggs and hence should serve as a component of the CDC2A-activation pathway.
Then, we measured MPF activity at different time points in each experimental group. In the Akt1-WT group, MPF activity reached its peak value at 27.5 h after the hCG injection, about 30 min earlier than in control groups (Fig. 3A) . In the myr-Akt1 group, the peak of MPF activity occurred at 26.5 h after the hCG injection, about 1.5 h earlier than the control group (Fig. 3B) . In the Akt1-KD group, MPF activity reached its peak value at 30 h after hCG injection, and the peak value was lower than that of the control groups (Fig. 3C) . The phosphorylation status of CDC2A-Tyr15 in each group was coincident with the MPF activity (Fig. 3D) . Meanwhile, we examined the expression of CCNB1 at the point of G2/M transition in each group, and there was no significant difference among the groups (Fig. 3E) . These results suggest that AKT can promote the cleavage of one-cell stage fertilized eggs by affecting the A) Embryos were collected from female mice that were injected with hCG; the embryos were then bathed in M16 medium and harvested at indicated times after the hCG administration. AKT was assayed by scintillation counting and autoradiography as described in the Materials and Methods section. B) The MPF activity was determined with histone H1 as substrate following microinjection of TE buffer. For each point, eggs were lysed and examined by scintillation counting and autoradiography. At least three independent experiments were performed.
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phosphorylation of CDC2A-Tyr15, directly or indirectly, and then increasing the activity of MPF.
The AKT/CDC25B Pathway Operates in Regulating the Division of One-Cell Stage Fertilized Eggs
CDC25B acts as an initiator of early mitotic events [35] , and it plays a role in the activation of a centrosomal subpopulation of CDC2A-CCNB1 that is next translocated to the nucleus where activation of CDC25C will initiate an amplification loop driving the cell into mitosis [36, 37] . It has been reported that in Hela cells, AKT phosphorylates CDC25B on serine 353, resulting in a nuclear export-dependent cytoplasmic accumulation of this phosphatase [38] . We then tested whether AKT can directly act on and promote CDC25B activation (a potential substrate for AKT) in mouse fertilized eggs. We used Scansite software (http://scansite.mit.edu) and the Clustal W(1.83) multiple sequence alignment program (http://www. ebi.ac.uk/clustalw/) to predict the relevant target sites of AKT on mouse CDC25B. We finally found that mouse CDC25B has a serine residue at position 351 (Ser351), which corresponds to Ser353 of human CDC25B, a residue phosphorylated by human AKT. We therefore injected one-cell stage eggs first with Akt1-WT mRNA or myr-Akt1 mRNA, as mentioned above, and then with mRNA encoding either wild-type CDC25B (Cdc25b-WT) or an AKT-nonphosphorylatable Ser351 to Ala CDC25B mutant (Cdc25b-S351A). Embryos coexpressed with Akt1 and Cdc25b-S351A remained at onecell stage 28 h after hCG injection, and only 9.64% of total embryos reached two-cell stage 30 h after hCG. Even in the   FIG. 3 . Effect of Akt1 mRNA microinjection on MPF activity and CDC2A-Tyr15 phosphorylation. Histone H1 kinase (MPF) activity was assayed following microinjection of 0.03 ng Akt1-WT mRNA (A), 0.03 ng myr-Akt1 mRNA (B), and 0.03 ng Akt1-KD mRNA (C). For each point, eggs were lysed and MPF activity was examined by scintillation counting and autoradiography. Each value was expressed as mean 6 SEM from three independent experiments. D) Western blot analysis of phosphorylation status of CDC2A-Tyr15. One-cell stage eggs injected with TE buffer were collected only 28 h after hCG injection. The eggs injected with Akt1-WT mRNA, myr-Akt1 mRNA, or Akt1-KD mRNA were collected 26.5 h and 28 h after hCG injection. E) The expression of CCNB1 in mouse eggs after Akt1 mRNA microinjection. One-cell stage eggs injected with TE buffer, Akt1-WT mRNA or Akt1-KD mRNA were collected 28 h after hCG injection; and the eggs injected with myr-Akt1 mRNA were collected 26.5 hr after hCG injection. The results of one representative experiment were presented. (Fig. 4) . Meanwhile, the Cdc25b-S351A mutant can inhibit the activation of MPF and affect the phosphorylation status of CDC2A-Tyr15 (Fig. 5, A-C) . In these experiments, the AKTnonphosphorylatable CDC25B mutant (Cdc25b-S351A), but not Cdc25b-WT, was able to block the (maturation-promoting) effect of overexpressed Akt1-WT or myr-Akt1. These results suggest strongly that AKT may directly phosphorylate CDC25B on Ser351 and can promote its function in mouse fertilized eggs. Taken together, the present results indicate that the AKT/CDC25B pathway can operate in regulating mitotic division of one-cell stage fertilized eggs.
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DISCUSSION
AKT is a signaling molecule that is known to enhance cell proliferation, survival, and glycogen and protein synthesis. Here we provide evidence for an important role of this kinase in the control of the first round of mitosis of mouse fertilized eggs. AKT overexpression in mouse fertilized eggs promoted cell division, and exogenous expression of myr-Akt1 further enhanced this effect. However, overexpression of Akt1-KD inhibited the development of mouse fertilized eggs. So, we propose that AKT is a key promoter of the first round of mitosis in mouse fertilized eggs. Although the Akt1-WT partially promoted early embryo division, its effect was much less efficient than the myr-AKT. Because the only difference between Akt1-WT and myr-AKT is their different abilities to interact with the lipid bilayer [26, 27, 33, 34] , we can conclude that AKT interaction with lipids is essential for signaling during early embryo division.
It is known that AKT participates in all physiological functions by phosphorylating a wide array of substrate proteins, including metabolic enzymes, structural proteins, transcription factors, and so on. Among them, GSK-3B was the first physiological target of AKT to be identified and is a key player in AKT signaling [39] . PI-kinase-induced activation of AKT results in AKT phosphorylation of both GSK-3B isoforms (Ser9 of GSK-3b; Ser21 of GSK-3a), which inhibits GSK-3B activity. Then, AKT-dependent inactivation of GSK-3B promotes the dephosphorylation and activation of the many substrates of GSK-3B [40] . We examined the phosphorylation status of GSK-3B in mouse eggs of the Akt1-WT and myr-Akt1 injection groups and noticed that overexpression of Akt1 constructs, especially overexpression of myr-Akt1, could facilitate the phosphorylation of both GSK-3B isoforms. But beyond our expectation, when we mutated Ser9 of GSK-3b and Ser21 of GSK-3a to nonphosphorylatable alanine, we found that these mutations couldn't interfere with the time course of cell division of one-cell stage fertilized eggs (Bingzhi Yu, unpublished data). Others also reported that phosphorylation of the Drosophila homologue of GSK-3B plays no role in the regulation of development or cell size and number [41] , and the finding that both the single and double GSK-3B knockin mice develop normally and are of normal size confirms these observations in a mammalian system [42] . Taken together, all these indicate that PI3K/AKT-mediated GSK-3 phosphorylation does not play a major role in regulating development, cell growth, and proliferation.
Then we further investigated the physiological substrates of AKT and the molecular basis for the regulation of the cell cycle by AKT in mouse fertilized eggs. It is well-known that MPF is a critical regulator of early embryo development in mice [43, 44] , and the MPF activity is regulated by phosphorylation. In this study, we showed that endogenous AKT activation occurs prior to MPF activation; moreover, AKT, especially the myr-AKT, promoted the initiation of MPF activation by affecting the phosphorylation status of CDC2A-Tyr15. These results suggest that AKT may be an upstream regulator of MPF activation, similar to its role in the maturation of the starfish Asterina pectinifera, Xenopus, and mouse oocyte [23, 45, 46] . Furthermore, we also noticed that in the AKT-KD overexpression group, more than 45% of the eggs reached two-cell stage, accompanied with the activation of MPF, if the culture time is extended to 35 h after hCG injection (data not shown). In support of our findings, others have also reported that inhibiting PI3K-AKT signaling in mouse oocytes with LY-294002 totally prevents resumption of meiosis at 55 min when control oocytes have already undergone GVBD, and more than 50% of these oocytes undergo GVBD at 2 h of culture [45] . These data suggest that alternative pathways leading to MPF activation exist and act synergistically with the AKT pathway.
In primary oocytes from the starfish Asterina pectinifera, AKT was reported to inhibit MYT 1 through AKT-dependent phosphorylation and down-regulation at the G2/M transition [23] . Moreover, in HEK293T cells, AKT promotes G2/M cellcycle progression by inducing phophorylation-dependent YWHAQ binding and cytoplasmic localization of WEE 1 kinase [24] . Thus, AKT may shift the balance during G2/M transition in favor of the dephosphorylated and activated CDC2A required for mitotic entry.
It is known that CDC2A activity is regulated by phosphorylation. CDC2A activity is inhibited by phosphorylation on Ser14 and Tyr15 catalyzed by WEE 1/MYT 1 kinase. Tyr15 is a target for CDC25 phosphatase, and activated CDC25 dephosphorylates CDC2A on Tyr15, which activates CDC2A. In humans, three CDC25 isoforms have been identified, and two of them, CDC25B and CDC25C phosphatases, have roles in regulating G2/M progression [35] . In vivo, CDC25B is active during G2 phase before CDC25C is activated at the G2/M transition [47] [48] [49] , and CDC25B is more efficient than CDC25C in promoting mitosis [50, 51] . FIG. 4 . The division rate in cultured mouse embryos after Akt1 and Cdc25b mRNA co-injection. One-cell stage mouse embryos were microinjected first with 0.02 ng Akt1-WT mRNA or myr-Akt1 mRNA as described in the Materials and Methods and then, 1-2 h later, with mRNA encoding either wild-type Cdc25b (Cdc25b-WT) or a AKT-nonphosphorylatable Ser351 to Ala Cdc25b mutant (Cdc25b-S351A). The percentage of division was calculated after counting under a dissecting microscope 30 h after injection of hCG in female mice. The data were pooled from three experiments and are expressed as mean 6 SEM.
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These data indicate that CDC25B is the initiator of mitosis, whereas CDC25C acts to ensure full activation of MPF and thereby rapid entry into mitosis. CDC25B has been shown to be phosphorylated by a number of protein kinases including CSNK2A2 (previously known as CK2), CDK/CCNs, CHEK, MAPK, MAPKAP, AURKA, and PEG3 kinase, and these events have been shown to be responsible for changes in the localization and/or the activity of this phosphatase [52] [53] [54] [55] [56] [57] [58] . Recently, it was reported that in Hela cells, AKT can phosphorylate CDC25B on Ser353, resulting in a nuclear export-dependent cytoplasmic accumulation of the phosphatase [38] . Our data have extended these observations and explained the effect of the AKT/CDC25B pathway during the first round of mitosis of mouse fertilized eggs. Our results suggest that AKT may directly phosphorylate CDC25B on Ser351 and can promote its function during the first round of mitosis of mouse fertilized eggs.
The functions of proteins are firmly correlated with their subcellular localization. CDC25B localization was shown to depend on nuclear export signal and nuclear localization signal sequences and to be regulated through its interaction with YWHAQ proteins [59] [60] [61] [62] . CDC25B accumulation in the cytoplasm has been correlated with spindle formation and it was suggested that this phosphatase pool located in close FIG. 5. Effect of Akt1 and Cdc25b mRNA co-microinjection on MPF activity. A) One-cell stage mouse embryos were microinjected first with 0.02 ng Akt1-WT mRNA and then with mRNA encoding either wild-type Cdc25b (Cdc25b-WT) or a AKT-nonphosphorylatable Ser351 to Ala Cdc25b mutant (Cdc25b-S351A). B) One-cell stage mouse embryos were microinjected first with 0.02 ng myr-Akt1 mRNA and then with mRNA encoding a AKTnonphosphorylatable Ser351 to Ala Cdc25b mutant (Cdc25b-S351A). The injected eggs were cultured in M16 medium and collected at different time points. For each point, eggs were lysed and MPF activity was examined by scintillation counting and autoradiography. Each value was expressed as mean 6 SEM from three independent experiments. C) Western blot analysis of phophorylation status of CDC2A-Tyr15. One-cell stage eggs comicroinjected with Akt1-WT/Cdc25b-WT mRNA, Akt1-WT/Cdc25b-S351A mRNA, and myr-Akt1/Cdc25b-S351A mRNA were collected 28 h after hCG injection. The data shown are representative of three independent experiments. 566 FENG ET AL. vicinity of the centrosome was responsible for the activation of the cytoplasmic pool of MPF [48, 55, 63] . Recently, it has been shown that active MPF first appears at centrosomes in prophase, and CDC25B can specifically activate MPF on centrosomes [64, 65] . These results have indicated an important mitotic function of CDC25B in the cytoplasmic centrosome. In somatic cells, the centrosome is established as an integrator of positive and negative pathways for entry to mitosis [66] , and essential molecules such as CDC25B, CHEK1, AURKA, CDC2A/CCNB1, and active AKT are associated with the centrosome at G2/M transition [63, [67] [68] [69] , suggesting that AKT-dependent phosphorylation of CDC25B may be involved in the initiation of MPF activation in the centrosome. Indeed, we have predicted that there are nuclear export signals between 52 and 65 residues and nuclear localization signals between 343 and 352 residues on the mouse CDC25B sequence. According to our data, the most plausible phosphorylation site of AKT on the mouse CDC25B sequence, Ser351, was just located in the nuclear localization signal (Bingzhi Yu, unpublished data). So we deduced that CDC25B-S351 phosphorylation by AKT may have masked the nuclear localization signal and selectively reduced the rate of CDC25B nuclear import. This presumably results in more efficient exclusion of CDC25B from the nucleus, initiates the activation of MPF on the centrosome, and promotes the cell division of one-cell mouse fertilized eggs.
In conclusion, we have reported for the first time that AKT may phosphorylate CDC25B-S351 and then activate MPF to improve the cell division of mammalian early embryos. Further analysis of direct phosphorylation of AKT on CDC25B and the experiments about the subcellular localization of pCDC25B-S351 will be conducted, which will help us better understand the mechanism of the regulation of cell-cycle progression in early embryo development.
